Addus HomeCare Corporation (ADUS)
USD 105.0
(1.04%)
USD 105.0
(1.04%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.05 Billion USD | 11.31% |
| 2022 | 951.12 Million USD | 10.02% |
| 2021 | 864.49 Million USD | 13.04% |
| 2020 | 764.77 Million USD | 17.88% |
| 2019 | 648.79 Million USD | 25.22% |
| 2018 | 518.11 Million USD | 21.71% |
| 2017 | 425.71 Million USD | 6.25% |
| 2016 | 400.68 Million USD | 18.96% |
| 2015 | 336.81 Million USD | 7.63% |
| 2014 | 312.94 Million USD | 17.67% |
| 2013 | 265.94 Million USD | 8.85% |
| 2012 | 244.31 Million USD | -10.54% |
| 2011 | 273.1 Million USD | 0.5% |
| 2010 | 271.73 Million USD | 4.79% |
| 2009 | 259.3 Million USD | 9.73% |
| 2008 | 236.3 Million USD | 21.45% |
| 2007 | 194.56 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 289.78 Million USD | 1.0% |
| 2024 Q1 | 280.74 Million USD | 1.59% |
| 2024 Q2 | 286.92 Million USD | 2.2% |
| 2023 Q3 | 270.72 Million USD | 4.13% |
| 2023 Q2 | 259.98 Million USD | 3.33% |
| 2023 Q4 | 276.35 Million USD | 2.08% |
| 2023 Q1 | 251.59 Million USD | 1.84% |
| 2023 FY | 1.05 Billion USD | 11.31% |
| 2022 Q4 | 247.05 Million USD | 2.73% |
| 2022 Q2 | 236.94 Million USD | 4.55% |
| 2022 FY | 951.12 Million USD | 10.02% |
| 2022 Q1 | 226.63 Million USD | 0.89% |
| 2022 Q3 | 240.49 Million USD | 1.5% |
| 2021 Q2 | 217.89 Million USD | 6.13% |
| 2021 Q1 | 205.3 Million USD | 4.75% |
| 2021 FY | 864.49 Million USD | 13.04% |
| 2021 Q3 | 216.66 Million USD | -0.56% |
| 2021 Q4 | 224.64 Million USD | 3.68% |
| 2020 Q4 | 195.99 Million USD | 1.04% |
| 2020 FY | 764.77 Million USD | 17.88% |
| 2020 Q3 | 193.98 Million USD | 5.1% |
| 2020 Q1 | 190.21 Million USD | 0.09% |
| 2020 Q2 | 184.57 Million USD | -2.97% |
| 2019 Q4 | 190.04 Million USD | 11.92% |
| 2019 Q2 | 149.69 Million USD | 7.5% |
| 2019 FY | 648.79 Million USD | 25.22% |
| 2019 Q1 | 139.25 Million USD | -0.39% |
| 2019 Q3 | 169.8 Million USD | 13.43% |
| 2018 Q1 | 109.44 Million USD | -2.24% |
| 2018 Q4 | 139.8 Million USD | 1.58% |
| 2018 FY | 518.11 Million USD | 21.71% |
| 2018 Q3 | 137.63 Million USD | 4.87% |
| 2018 Q2 | 131.23 Million USD | 19.91% |
| 2017 Q1 | 101.6 Million USD | -1.98% |
| 2017 Q4 | 111.95 Million USD | 3.1% |
| 2017 Q3 | 108.59 Million USD | 4.86% |
| 2017 FY | 425.71 Million USD | 6.25% |
| 2017 Q2 | 103.55 Million USD | 1.92% |
| 2016 FY | 400.68 Million USD | 18.96% |
| 2016 Q3 | 103.5 Million USD | 2.55% |
| 2016 Q2 | 100.92 Million USD | 8.99% |
| 2016 Q1 | 92.6 Million USD | 9.25% |
| 2016 Q4 | 103.65 Million USD | 0.15% |
| 2015 Q3 | 84.33 Million USD | -1.72% |
| 2015 FY | 336.81 Million USD | 7.63% |
| 2015 Q4 | 84.76 Million USD | 0.51% |
| 2015 Q2 | 85.8 Million USD | 4.75% |
| 2015 Q1 | 81.91 Million USD | -0.87% |
| 2014 Q1 | 71.68 Million USD | 2.58% |
| 2014 Q2 | 136.67 Million USD | 90.66% |
| 2014 Q3 | 81.65 Million USD | -40.25% |
| 2014 Q4 | 82.63 Million USD | 1.2% |
| 2014 FY | 312.94 Million USD | 17.67% |
| 2013 Q2 | 65.75 Million USD | 4.38% |
| 2013 Q3 | 67.3 Million USD | 2.36% |
| 2013 Q4 | 69.88 Million USD | 3.83% |
| 2013 FY | 265.94 Million USD | 8.85% |
| 2013 Q1 | 62.99 Million USD | -1.22% |
| 2012 Q2 | 70.28 Million USD | 3.47% |
| 2012 FY | 244.31 Million USD | -10.54% |
| 2012 Q4 | 63.77 Million USD | -10.18% |
| 2012 Q1 | 67.92 Million USD | -1.02% |
| 2012 Q3 | 71 Million USD | 1.03% |
| 2011 FY | 273.1 Million USD | 0.5% |
| 2011 Q1 | 66.84 Million USD | -4.67% |
| 2011 Q2 | 68.25 Million USD | 2.11% |
| 2011 Q3 | 69.38 Million USD | 1.66% |
| 2011 Q4 | 68.62 Million USD | -1.1% |
| 2010 Q2 | 67.16 Million USD | 3.96% |
| 2010 Q1 | 64.6 Million USD | -1.66% |
| 2010 Q4 | 70.12 Million USD | 0.4% |
| 2010 Q3 | 69.84 Million USD | 3.99% |
| 2010 FY | 271.73 Million USD | 4.79% |
| 2009 Q2 | 64.96 Million USD | 5.06% |
| 2009 Q3 | 66.8 Million USD | 2.83% |
| 2009 FY | 259.3 Million USD | 9.73% |
| 2009 Q4 | 65.69 Million USD | -1.66% |
| 2009 Q1 | 61.83 Million USD | -1.42% |
| 2008 Q4 | 62.72 Million USD | 0.03% |
| 2008 FY | 236.3 Million USD | 21.45% |
| 2008 Q3 | 62.7 Million USD | 0.0% |
| 2007 FY | 194.56 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 63.853% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | -440.357% |
| Amedisys, Inc. | 2.23 Billion USD | 52.662% |
| Astrana Health, Inc. | 1.38 Billion USD | 23.655% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 44.141% |
| IMAC Holdings, Inc. | 5.19 Million USD | -20270.425% |
| biote Corp. | 185.36 Million USD | -471.132% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -3277.556% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 47.584% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | -69.577% |
| The Ensign Group, Inc. | 3.72 Billion USD | 71.613% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | 36.66% |
| InnovAge Holding Corp. | 763.85 Million USD | -38.593% |
| The Joint Corp. | 117.69 Million USD | -799.476% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | -0.283% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -10120.102% |
| ModivCare Inc. | 2.75 Billion USD | 61.52% |
| NewGenIvf Group Limited | 5.13 Million USD | -20511.75% |
| Option Care Health, Inc. | 4.3 Billion USD | 75.394% |
| P3 Health Partners Inc. | 1.26 Billion USD | 16.403% |
| P3 Health Partners Inc. | 1.26 Billion USD | 16.403% |
| The Pennant Group, Inc. | 544.89 Million USD | -94.287% |
| Surgery Partners, Inc. | 2.74 Billion USD | 61.41% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -19095.346% |
| Talkspace, Inc. | 150.04 Million USD | -605.556% |
| Talkspace, Inc. | 150.04 Million USD | -605.556% |
| The Oncology Institute, Inc. | 324.23 Million USD | -226.503% |
| The Oncology Institute, Inc. | 324.23 Million USD | -226.503% |